Dar. Deberker et al., SEBACEOUS HYPERPLASIA IN ORGAN TRANSPLANT RECIPIENTS - SHARED ASPECTSOF HYPERPLASTIC AND DYSPLASTIC PROCESSES, Journal of the American Academy of Dermatology, 35(5), 1996, pp. 696-699
Background: Patients receiving kidney or heart transplants are subject
to a wide range of cutaneous changes attributed largely to the immuno
suppression required to prevent rejection of their transplant. In addi
tion to infection, they have an increased incidence of dysplastic lesi
ons, some of which are malignant. Objective: Our purpose was to determ
ine the incidence of sebaceous hyperplasia in heart and kidney transpl
ant recipients and its association with neoplasia.Methods: Patients un
dergoing heart transplantation from a single transplant center were ex
amined during a 30-month screening period to establish the prevalence
of cutaneous abnormalities. Results: Sixteen of 104 (16%) heart transp
lant recipients had sebaceous hyperplasia in comparison with 1% of an
age- and sex-matched control group. Those with sebaceous hyperplasia d
id not have a significantly higher incidence of hypertrichosis than th
ose without sebaceous hyperplasia. Conclusion: Sebaceous hyperplasia i
s seen in heart transplant recipients. It does not appear to be connec
ted with hypertrichosis, in which it is believed that the pilosebaceou
s unit is the target of the direct effects of cyclosporine. We propose
that the development of sebaceous hyperplasia is related to the proce
ss of dysplastic epithelial proliferation in transplant recipients.